Summary
CME Group Inc. (CME) announced a key leadership transition in its finance department via an 8-K filing. Effective April 1, 2023, Lynne Fitzpatrick will assume the role of Chief Financial Officer, succeeding John W. Pietrowicz, who is retiring from the CFO position but will remain with the company as a Special Advisor until December 31, 2023. This transition represents a planned succession, with Ms. Fitzpatrick's extensive experience within CME Group's finance organization, including her recent role as Senior Managing Director & Deputy Chief Financial Officer, positioning her well for the CFO responsibilities. Ms. Fitzpatrick's tenure at CME Group dates back to 2006, and she has held various leadership positions, notably leading business development, M&A, CME Ventures, and corporate treasury. Her appointment to CFO is expected to maintain continuity in financial strategy and operations. The filing also confirms no immediate concerns regarding family relationships or related-party transactions involving Ms. Fitzpatrick.
Key Highlights
- 1Lynne Fitzpatrick appointed Chief Financial Officer (CFO) effective April 1, 2023.
- 2Current CFO John W. Pietrowicz to retire from CFO role but will serve as Special Advisor until December 31, 2023.
- 3The CFO transition is a planned succession.
- 4Fitzpatrick has extensive experience within CME Group, holding roles including Senior Managing Director & Deputy CFO, and leading Corporate Development and Treasurer functions.
- 5Fitzpatrick's compensation as CFO will be commensurate with other executive officers at the Senior Managing Director level.
- 6No family relationships exist between Ms. Fitzpatrick and any executive officer or director of CME Group.
- 7No related-party transactions involving Ms. Fitzpatrick or her immediate family are disclosed.